Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 152Recruiting 48Unknown 41Terminated 38Active not recruiting 18Withdrawn 14Not yet recruiting 8Suspended 3No longer available 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Gastrointestinal 1Breast 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 5Carcinoma, Non-Small-Cell Lung 3Solid Tumor 2Retinoblastoma 2Mesothelioma 2Advanced Solid Tumor 2von Willebrand Disease, Type 3 1beta-Thalassemia 1Xanthomatosis, Cerebrotendinous 1X-Linked Combined Immunodeficiency Diseases 1Wolman Disease 1Waardenburg syndrome type 2A 1Waardenburg syndrome type 2 1Waardenburg Syndrome 1VLCAD deficiency 1Usher syndrome, type 1F 1Usher syndrome, type 1C 1Usher syndrome, type 1B 1Tyrosinemias 1Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Triple Negative Breast Neoplasms 1Trifunctional Protein Deficiency With Myopathy And Neuropathy 1Thyroid Dyshormonogenesis 6 1Thyroid Dyshormonogenesis 5 1Thyroid Dyshormonogenesis 3 1Thyroid Dyshormonogenesis 2A 1Thyroid Dyshormonogenesis 1 1Thymus Neoplasms 1Thymoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Mesothelioma, Malignant × Other solid neoplasm × Clear all
NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ï¼»18Fï¼½FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Stella Pharma Corporation

Phase 1/2 Enrolling by invitation
30 enrolled
BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡